biotech finance
The Trillion-Dollar Bug: How AI and New Financial Models Are Fuelling the War on Superbugs
A new GSK-backed venture uses AI and innovative financial models to combat the growing economic and health threat of drug-resistant superbugs.
The $600M Bet: How the Global Race for Weight-Loss Drugs is Rewriting the Rules of Biotech Investing and Tapping into China’s R&D Power
A US biotech’s $600M raise for weight-loss drugs reveals a key strategy: using China for faster, cheaper clinical trials, altering biotech investing.